Skip to content
HW211207 25950 ÔÇô HER2 Targeted Therapies logo (002)

Returning 2023

  • Home
  • About
    • About Event
  • What’s On
    • 2022 Full Event Guide
    • 2022 Speaker Faculty
  • Partner
    • Partnership Opportunities
    • 2022 Partners
  • Register Interest
    • Register Interest
    • Contact Us
What’s On › Speaker Faculty

Finola Moore

Director of Pipeline, Research

CatamaranBio

Aleix Prat

Chief Scientific Officer & Co-founder

REVEAL GENOMICS

Michael C Dugan

Senior Vice President, Chief Medical Officer & Medical Director

Biocept

Neha Pant

Global Program Lead, Cinrebafusp alfa

Pieris Pharmaceuticals

Athanasios Tsiatis

Senior Vice President - Clinical Development

ALX Oncology

Cecile Geuijen

Chief Scientific Officer & Vice President - Oncology

Merus

Roger Waltzman

Chief Medical Officer

Molecular Templates

Edith Perez

Chief Medical Officer

Bolt Biotherapeutics

Fredrik Frejd

Chief Scientific Officer

Affibody

Gail D. Lewis

Principal Scientist, Discovery Oncology

Genentech

Reva Basho

Assistant Professor, Breast Medical Oncology, Co-Director: Women’s Cancer Research Program

Cedars-Sinai Medical Center

Finola Moore

Director of Pipeline, Research

CatamaranBio

John Strickler

Associate Professor of Medicine

Duke Clinical Research Institute

Harshabad Singh

Instructor in Medicine

Division of Gastrointestinal Oncology, Dana-Farber Cancer Institute

Deyaa Adib

Chief Medical Officer

Triumvira Immunologics

Fiore Cattaruzza

Senior Director of Translational Biomarkers

Amunix Pharmaceuticals

RJ Tesi

Chief Executive & Medical Officer

Inmune Bio

Funda Meric – Bernstam

Chair, Department of Investigational Cancer Therapeutics & Medical Director

Institute for Personalized Cancer Therapy, MD Anderson Cancer Center

Nancy Lin

Associate Professor, Medicine, Active Staff, Adult Oncology, Clinical Director, Breast Oncology Center, Medical Oncology

Harvard Medical School, Dana-Farber Cancer Institute

Roxana Schillaci

Principal Researcher

Institute of Biology and Experimental Medicine CONICET, Argentina

Aparna Parikh

Assistant Professor & Director

Harvard Medical School & MGH Cancer Center's Global Cancer Care Program

Zenta Tsuchihashi

Senior Director, Translational Science Lead, ENHERTU program

Daiichi Sankyo

Serena Masciari

Senior Medical Director, Oncology Early Development

Sanofi Genzyme

Paul Rennert

President & Chief Scientific Officer

Aleta Biotherapeutics

Nicholas Choong

Vice President of Clinical Development

Seagen

Samuel J. Klempner

GI Oncology, MGH Cancer Center

Harvard Medical School

Phoebe Harvey

Medical Director, Clinical Research

Zymeworks

Jonathan Dry

Vice President, Scientific Discovery

Tempus

Event Guide Banners

OUR CONTACT DETAILS

T: +1 617 455 4188
E: info@hansonwade.com

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

DATES

Returning in 2023

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok